Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TOVX will decline by -9.27% over the next 2 Weeks and hit $0.17 by Wednesday, March 4, 2026. In that time frame, TOVX's share price is expected to range between $0.16 and $0.19.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 4, 2026 | 0.16 | 0.17 | 0.19 |
| Mar 3, 2026 | 0.16 | 0.17 | 0.19 |
| Mar 2, 2026 | 0.16 | 0.18 | 0.20 |
| Feb 27, 2026 | 0.17 | 0.19 | 0.21 |
| Feb 26, 2026 | 0.16 | 0.18 | 0.20 |
| Feb 25, 2026 | 0.16 | 0.18 | 0.20 |
| Feb 24, 2026 | 0.16 | 0.18 | 0.20 |
| Feb 23, 2026 | 0.17 | 0.18 | 0.20 |
| Feb 20, 2026 | 0.17 | 0.19 | 0.21 |
| Feb 19, 2026 | 0.17 | 0.19 | 0.21 |
TOVX shares rose +2.45% in Thursday, February 19, 2026's trading session, rising from a previous close of $0.19 to move at $0.20. The stock demonstrated notable intraday movement (see TOVX's key stats for a full breakdown), fluctuating between $0.20 and $0.26, a +31.72% trading range. While recent weeks have seen some volatility, TOVX has managed to secure a -1.60% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 271.3M shares changing hands, 263.77M more than the previous session. This amounted to $53.37M in total market activity.
Will TOVX Continue Its Downward Trend?
According to analyst ratings and projections for TOVX, Theriva Biologics, Inc. shares are anticipated to decrease by -2.06%, potentially reaching $0.19 per share by March 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for TOVX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the TOVX stock forecast, now is not the best time to buy TOVX stock because its current trading price is +12.92% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TOVX covering social and institutional perspectives.
TOVX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TOVX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.39% to 52.45%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.20%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.43%, maintains a neutral outlook for the long term. Insights into TOVX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Theriva Biologics Short-Term Forecasts
TOVX Forecast For Next 5 Days
Our algorithm anticipates Theriva Biologics (TOVX) stock could hit $0.21 by Feb 26, 2026. This represents a +8.39% fall from today's price, following a -16.97% change over the past five days.
TOVX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Theriva Biologics, Inc. (TOVX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.19, which would mean a -3.41% decrease from the current price of $0.20. Projections for this period range from a high of $0.23 to a low of $0.14.
TOVX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Theriva Biologics's price over the next three months point to a rise. TOVX stock is expected to peak at $0.58 on Mar 23, 2026 before potentially dipping to $0.00 on May 19, 2026. On average, TOVX is likely to trade around $0.23 in the coming 90 days.
Theriva Biologics Stock Forecast 2025
Based on our predictive models, Theriva Biologics (TOVX) is expected to trade between $0.00 and $0.58 throughout 2026. This would result in an average price of $0.13, potentially offering investors a -33.91% return from current levels.
Theriva Biologics, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Theriva Biologics, Inc. (TOVX) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $0.56, settling at an average of $0.25. This could translate to a +27.10% gain.
March 2026
Based on current market signals, Theriva Biologics, Inc. is projected to trend march 2026. We forecast a trading range from $0.00 to $0.58, with a likely average price of $0.27. Investors could expect a potential return of +37.26%.
April 2026
Our predictive algorithms indicate Theriva Biologics, Inc. stock may see a shift in April 2026. The expected range spans $0.00–$0.54, with an average target of $0.22. This represents a positive outlook and a possible gain of +11.85%.
May 2026
Analyzing established trends, Theriva Biologics, Inc. looks set to move in May 2026. Projections place the stock between $0.00 and $0.49, averaging around $0.19. This suggests a -3.41% loss from current levels.
June 2026
Market indicators suggest Theriva Biologics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.48, with a midpoint forecast of $0.16. The stock might deliver a -18.66% loss.
July 2026
Forecasting for July 2026, models estimate that Theriva Biologics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.42, averaging $0.10. This signals a cautious trajectory with potential returns around -49.16%.
August 2026
According to our latest forecast models, Theriva Biologics, Inc. (TOVX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.41, settling at an average of $0.10. This could translate to a -49.16% loss.
September 2026
Based on current market signals, Theriva Biologics, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $0.36, with a likely average price of $0.08. Investors could expect a potential return of -59.33%.
October 2026
Our predictive algorithms indicate Theriva Biologics, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$0.41, with an average target of $0.06. This represents a cautious outlook and a possible loss of -69.50%.
November 2026
Analyzing established trends, Theriva Biologics, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $0.36, averaging around $0.04. This suggests a -79.66% loss from current levels.
December 2026
Market indicators suggest Theriva Biologics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.34, with a midpoint forecast of $0.03. The stock might deliver a -84.75% loss.
January 2027
Forecasting for January 2027, models estimate that Theriva Biologics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.33, averaging $0.04. This signals a cautious trajectory with potential returns around -79.66%.
February 2027
According to our latest forecast models, Theriva Biologics, Inc. (TOVX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.35, settling at an average of $0.04. This could translate to a -79.66% loss.
TOVX's history of dividends and stock splits also plays a role in long-term investor confidence.

